Company intelligence / Profile preview

Mediteo

Ownership: Private
Development stage: Other

Overview

Mediteo provides an award-winning, ISO-certified digital health app that helps patients manage their medications, supports therapy adherence, enables integration of personal therapy plans, and delivers real-world data insights for healthcare partners. The platform is used by millions of patients daily and has received multiple quality awards in Germany[2].

Therapeutic areas: Other
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Mediteo collaborates with pharmaceutical companies for patient engagement projects using its digital platform to deliver information directly to users' smartphones. It also offers real-world data insights to industry partners[2]. Specific partner names are not listed.

Beyond the preview

Go deeper on Mediteo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediteo.

Explore the full profile